Aerosol formulation for inhalation comprising an anticholinergic

US7579358B2 · kind B2 · utility

Assignee

• Boehringer Ingelheim International GmbH · DE

Inventors

• Georg Boeck · Mainz, DE
• Friedrich Schmidt · Minto, CA

Key dates

• Filing date: Sep 7, 2004
• Grant date: Aug 25, 2009
• Expiry date: Dec 6, 2024

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A pharmaceutical composition comprising: wherein X− is an anion;